ngµç×ÓÓÎÏ·

03
Ê×Ò³ / ½Ìѧ¿ÆÑÐ / ÕýÎÄ

ngµç×ÓÓÎÏ·ÁÖÌìì§½ÌÊÚÍŶÓÕ¹ÏÖÔçÆÚ°òë×°©Âö¹Ü°©Ë¨ÐγɵÄÒªº¦·Ö×Ó»úÖÆ

¸å¼þȪԴ£º£ºËïÒÝÏɼÍÄîÒ½Ôº ±à¼­£º£ºÌ¸Ï£¡£¡¢¡¢Â¬ì½Î¬ ÉóºË£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÁÖèòç÷£©ÁܰÍ×ªÒÆÊÇÓ°Ïì°òë×°©Ô¤ºóµÄ×îÖ÷ÒªÒòËØÖ®Ò»¡£¡£¡£ÔÚÁÙ´²ÉÏ£¬±£´æ²¿·ÖÔçÆÚÖ×Áö¸ººÉ½ÏСµ«È´·ºÆðÁܰÍ×ªÒÆµÄ°òë×°©£¬ÆäÔ¤ºó¼«²î£¬·Ö×Ó»úÖÆÉв»ÇåÎú¡£¡£¡£¿ËÈÕ£¬ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºÁÖÌìì§½ÌÊÚÍŶÓÕ¹ÏÖÁËÖ×ÁöÏà¹Ø³ÉÏËάϸ°ûÑÇȺ½éµ¼°òë×°©Âö¹Ü°©Ë¨ÐγɵÄлúÖÆ£¬Ñо¿Ð§¹ûÓÚ2024Äê2ÔÂ29ÈÕÔÚ¹ú¼Ê¶¥¼¶ÆÚ¿¯¡¶Cancer Cell¡·½ÒÏþ£¬ÌâΪ¡°PDGFR¦Á+ITGA11+ fibroblasts foster early-stage cancer lymphovascular invasion and lymphatic metastasis via ITGA11-SELE interplay¡±¡£¡£¡£

ngµç×ÓÓÎÏ·ËïÒÝÏɼÍÄîÒ½ÔºÁÖÌìì§½ÌÊÚ¡¢¡¢³Â³¤ê»¸±½ÌÊÚΪͨѶ×÷Õß¡£¡£¡£Ö£º£ºººÀ²©Ê¿¡¢¡¢°²Ã÷½Ü²©Ê¿¡¢¡¢ÂÞÓîÃ÷²©Ê¿ºÍµóÏÄÒ¢²©Ê¿ÎªÅäºÏµÚÒ»×÷Õß¡£¡£¡£ÔÚ¹ú¼ÒÓÅÒìÇàÄê»ù½ðÏîÄ¿¡¢¡¢¹ú¼ÒÖØµãÑз¢ÍýÏëÏîÄ¿¡¢¡¢¹ú¼Ò×ÔÈ»»ù½ðÖØµãÏîÄ¿¡¢¡¢¹ú¼Ò×ÔÈ»ÁªºÏ»ù½ðÖØµãÏîÄ¿µÄÖ§³ÖÏ£¬Ñо¿Ö°Ô±Ê¹Óõ¥Ï¸°û²âÐòÊ×ÏÈÆÊÎöÁËÔçÆÚ°òë×°©Ö×Áö΢ÇéÐεÄϸ°û×é³ÉÌØÕ÷£¬²¢ÅжÏÁËÓëÔçÆÚÁܰ͹ܰ©Ë¨Ïà¹ØµÄÖ×ÁöÏà¹Ø³ÉÏËάϸ°ûÑÇȺ£º£ºPDGFR¦Á+ITGA11+ CAFs¡£¡£¡£Í¨¹ýת»ùÒòСÊóÄ£×Ó֤ʵ£¬Ìõ¼þÐÔÇóýPDGFR¦Á+ITGA11+ CAFsÏÔÖøÒÖÖÆÔçÆÚ°òë×°©Áܰ͹ܰ©Ë¨Ðγɼ°ÁܰÍ×ªÒÆµÄ±¬·¢¡£¡£¡£½øÒ»²½µÄ·Ö×Ó»úÖÆÑо¿·¢Ã÷£¬PDGFR¦Á+ITGA11+ CAFsͨ¹ýITGA11ʶ±ðÁܰ͹ÜÄÚÆ¤Ï¸°ûĤÉÏÊÜÌåÂѰ×SELE¶ø¼¤»îSRC/p-VEGFR3/MAPKÐźÅÖᣬÔö½ø°òë×°©Áܰ͹ÜÐÂÉú¡£¡£¡£±ðµÄ£¬PDGFR¦Á+ITGA11+ CAFs½øÒ»²½ÉøÍ¸CHI3L1ÖØËÜϸ°ûÍâ»ùÖʽ鵼Ö×Áöϸ°û½þÈóÁܰ͹ÜÐγÉÂö¹Ü°©Ë¨£¬×îÖÕµ¼ÖÂÁܰÍ×ªÒÆ¡£¡£¡£

303094ADB7AFB7A6EB552BB8EA9_452636D6_206D0

×ܵÄÀ´Ëµ£¬±¾Ñо¿Ê×´ÎÆÊÎöÁËPDGFR¦Á+ITGA11+ CAFsÑÇȺͨ¹ýITGA11-SELEÅäÊÜÌ廥×÷ÓÕµ¼Áܰ͹ÜÐÂÉú£¬²¢ÖØËÜϸ°ûÍâ»ùÖʽ鵼Ö×Áöϸ°ûÇÖÏ®½þÈóÁܰ͹Ü£¬Ôö½øÔçÆÚ°òë×°©Âö¹Ü°©Ë¨ÐγɵÄÒªº¦·Ö×Ó»úÖÆ£¬ÓÐÍûΪÔçÆÚ×è¶Ï°òë×°©ÁܰÍ×ªÒÆÌṩеĸÉÔ¤°Ðµã¡£¡£¡£

Ô­ÎÄÁ´½Ó£º£ºhttps://doi.org/10.1016/j.ccell.2024.02.002

¡¾ÍøÕ¾µØÍ¼¡¿